Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Paul Ausick | Oct 1, 2013 at 9:25 AM EDT

Merck Slashes Another 8,500 Jobs

ThinkstockDrugmaker Merck & Co. Inc. (NYSE: MRK) announced Tuesday morning that it will fire another 8,500 employees in an effort…

Jon C. Ogg | Sep 30, 2013 at 10:35 AM EDT

Five FDA Approvals and Reviews at Risk Under a Government Shutdown

via Wikimedia CommonsIt looks like Congress and the president still cannot figure out how to play well with each other,…

Jon C. Ogg | Sep 27, 2013 at 1:13 PM EDT

Nektar Pain Drug Sends Shareholders To Rehab

ThinkstockNektar Therapeutics (NASDAQ: NKTR) may have just burned a serious bridge for its future. The company is developing drugs for…

247alex | Sep 27, 2013 at 12:45 PM EDT

10 States With The Worst Health Coverage

ThinkStockLast year, just under 15% of the U.S. population did not have health insurance coverage. But as the different stages…

Paul Ausick | Sep 25, 2013 at 12:26 PM EDT

Foundation Medicine IPO Greeted with Open Wallets

Thinkstock Cancer-treatment company Foundation Medicine Inc. (NASDAQ: FMI) held its initial public offering (IPO) Wednesday morning. The company sold 5.9…

Jon C. Ogg | Sep 24, 2013 at 1:32 PM EDT

Contract Research Leaders Get Big Boost from Credit Suisse Analyst

ThinkstockCredit Suisse has initiated research coverage on the so-called contract services organizations, or CROs. The firm’s Jeffrey Bailin started the…

Lee Jackson | Sep 24, 2013 at 8:30 AM EDT

J.P. Morgan Highlights Health Care Stocks to Buy as Obamacare Kicks In

ThinkstockDespite Republican efforts to defund the Affordable Care Act, or Obamacare, it is looking increasingly likely that the program will…

Jon C. Ogg | Sep 18, 2013 at 1:30 PM EDT

Google Gets into Health Care with Launch of Calico Company, with an Apple Twist

ThinkstockGoogle Inc. (NASDAQ: GOOG) is known for many efforts outside of traditional search and traditional technology. Some think this is…

Jon C. Ogg | Sep 18, 2013 at 11:40 AM EDT

Analyst Sees Big Risks Lurking in Possible Biotech Buyout

ThinkstockViroPharma Inc. (NASDAQ: VPHM) has become the latest and greatest biotech buyout candidate after a report of it being a…

Lee Jackson | Sep 16, 2013 at 8:45 AM EDT

Wall Street Sees Big Biotech Making Tens of Billions in Two Critical Areas

ThinkstockInvestors make big money in biotechnology stocks when they focus on areas that cut across a wide swath of the…

Jon C. Ogg | Sep 11, 2013 at 6:24 PM EDT

Antipsychotic Drug Recall of Risperdal Consta by the Johnsons Over Mold

ThinkstockJohnson & Johnson (NYSE: JNJ) has been one of the great health care and consumer products survivors of our lifetimes.…

Mike Sauter | Sep 5, 2013 at 6:40 AM EDT

States Where the Most People Go Hungry

ThinkstockAn estimated 14.5 million American households had difficulty providing enough food for their families last year, according to a recent…

Lee Jackson | Sep 4, 2013 at 8:25 AM EDT

UBS Picks Large Cap Biotechnology Stocks to Outperform the Rest of 2013

ThinkstockEven though the equity strategy team at UBS has downgraded U.S. equities to Neutral from Outperform, they remain very positive…

Jon C. Ogg | Aug 26, 2013 at 1:29 PM EDT

Will Attorney Investigations or Class Action Suits Put Amgen-Onyx Buyout at Risk?

Jon OggAny time you see a merger announcement, you see a myriad of press releases pertaining to law firms and…

Jon C. Ogg | Aug 26, 2013 at 8:05 AM EDT

Lessons of Buying Growth Companies Doubling Their Revenues

ThinkstockAmgen Inc. (NASDAQ: AMGN) wants to regain its status as the largest publicly traded biotech in the U.S. The company formalized…

1 … 299 300 301 302 303 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Merck Slashes Another 8,500 Jobs

Five FDA Approvals and Reviews at Risk Under a Government Shutdown

Nektar Pain Drug Sends Shareholders To Rehab

10 States With The Worst Health Coverage

Foundation Medicine IPO Greeted with Open Wallets

Contract Research Leaders Get Big Boost from Credit Suisse Analyst

J.P. Morgan Highlights Health Care Stocks to Buy as Obamacare Kicks In

Google Gets into Health Care with Launch of Calico Company, with an Apple Twist

Analyst Sees Big Risks Lurking in Possible Biotech Buyout

Wall Street Sees Big Biotech Making Tens of Billions in Two Critical Areas

Antipsychotic Drug Recall of Risperdal Consta by the Johnsons Over Mold

States Where the Most People Go Hungry

UBS Picks Large Cap Biotechnology Stocks to Outperform the Rest of 2013

Will Attorney Investigations or Class Action Suits Put Amgen-Onyx Buyout at Risk?

Lessons of Buying Growth Companies Doubling Their Revenues

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

XRP vs Solana vs Ethereum: Which Altcoin is the Best Buy for Upside Right Now?

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

Health and Healthcare Articles

All Health and Healthcare Articles

Merck Slashes Another 8,500 Jobs

Five FDA Approvals and Reviews at Risk Under a Government Shutdown

Nektar Pain Drug Sends Shareholders To Rehab

10 States With The Worst Health Coverage

Foundation Medicine IPO Greeted with Open Wallets

Contract Research Leaders Get Big Boost from Credit Suisse Analyst

J.P. Morgan Highlights Health Care Stocks to Buy as Obamacare Kicks In

Google Gets into Health Care with Launch of Calico Company, with an Apple Twist

Analyst Sees Big Risks Lurking in Possible Biotech Buyout

Wall Street Sees Big Biotech Making Tens of Billions in Two Critical Areas

Antipsychotic Drug Recall of Risperdal Consta by the Johnsons Over Mold

States Where the Most People Go Hungry

UBS Picks Large Cap Biotechnology Stocks to Outperform the Rest of 2013

Will Attorney Investigations or Class Action Suits Put Amgen-Onyx Buyout at Risk?

Lessons of Buying Growth Companies Doubling Their Revenues

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

XRP vs Solana vs Ethereum: Which Altcoin is the Best Buy for Upside Right Now?

Featured Reads

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up